Rain Oncology
Newark
About Rain Oncology
Rain Oncology Inc. is a precision oncology company developing therapies that target oncogenic drivers to genetically select patients it believes will most likely benefit.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $82.4M
- Funding stage: M&A
- Last round: Series B (Sep 2020)
- Ticker: nasdaq:RAIN
- Website: rainoncology.com
- Phone: +1 510-953-5559
Industries & Categories
Biopharma, Biotechnology, Clinical Trials, Health Care, Oncology
Social Profiles
Canonical: https://fsome.com/organization/rain-oncology-106675 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.